Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia.

Walker, Alison R

Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia. [electronic resource] - Leukemia & lymphoma 09 2016 - 2100-8 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1029-2403

10.3109/10428194.2015.1135435 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Bortezomib--administration & dosage
Chromosome Aberrations
Cytarabine--administration & dosage
Drug Monitoring
Drug Resistance, Neoplasm
Etoposide--administration & dosage
Female
Humans
Leukemia, Myeloid, Acute--diagnosis
Male
Maximum Tolerated Dose
Middle Aged
Mitoxantrone--administration & dosage
Recurrence
Remission Induction
Retreatment
Staurosporine--administration & dosage
Treatment Outcome
Young Adult